Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
13.07
+0.20 (1.55%)
At close: Sep 18, 2026, 4:00 PM EDT
13.09
+0.02 (0.13%)
After-hours: Sep 18, 2026, 7:48 PM EDT
Replimune Group Employees
Replimune Group had 465 employees as of March 31, 2026. The number of employees decreased by 14 or -2.92% compared to the previous year.
Employees
465
Change (1Y)
-14
Growth (1Y)
-2.92%
Revenue / Employee
n/a
Profits / Employee
-$638,738
Market Cap
1.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 465 | -14 | -2.92% |
| Mar 31, 2025 | 479 | 148 | 44.71% |
| Mar 31, 2024 | 331 | 47 | 16.55% |
| Mar 31, 2023 | 284 | 78 | 37.86% |
| Mar 31, 2022 | 206 | 54 | 35.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MeiraGTx Holdings | 393 |
| Omeros | 175 |
| Maze Therapeutics | 141 |
| ORIC Pharmaceuticals | 111 |
| Odyssey Therapeutics | 100 |
| Apnimed | 81 |
| Vor Biopharma | 76 |
REPL News
- 1 day ago - REPL Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending October 5, 2026 Lead Plaintiff Deadline for Information About Recovering Their Losses - PRNewsWire
- 4 days ago - Replimune Group Transcript: AGM 2026 - Transcripts
- 9 days ago - Replimune Group Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 16 days ago - Replimune to Present at the Cantor Global Healthcare Conference 2026 - GlobeNewsWire
- 18 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL - GlobeNewsWire
- 24 days ago - Replimune price target raised to $21 from $20 at JPMorgan - TheFly
- 25 days ago - REPL Stockholders Have Rights – If You Lost Money Investing in Replimune Group, Inc. Contact Robbins LLP for Information About Recovering Your Losses - GlobeNewsWire
- 4 weeks ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire